Matches in Wikidata for { <http://www.wikidata.org/entity/Q91321154> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91321154 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91321154 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91321154 description "scientific article published on 18 November 2019" @default.
- Q91321154 description "wetenschappelijk artikel" @default.
- Q91321154 description "наукова стаття, опублікована 18 листопада 2019" @default.
- Q91321154 name "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 name "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 type Item @default.
- Q91321154 label "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 label "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 prefLabel "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 prefLabel "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 P1433 Q91321154-3265E740-B269-4B97-8B6A-C8138C98CA20 @default.
- Q91321154 P1476 Q91321154-14596385-8AE1-4177-894E-5430556FCC64 @default.
- Q91321154 P2093 Q91321154-180A4A51-5DB7-4135-AC85-441587F758B0 @default.
- Q91321154 P2093 Q91321154-1A310FED-4611-4760-8A6C-86E5CFF29BCA @default.
- Q91321154 P2093 Q91321154-253D83E3-22DB-4E54-99DD-87C65E9699E7 @default.
- Q91321154 P2093 Q91321154-4B29FE87-FC83-4E5D-9CA2-E5686DB73383 @default.
- Q91321154 P2093 Q91321154-4DABBE59-4737-4CC5-ADEB-8F9C569F4B63 @default.
- Q91321154 P2093 Q91321154-881E9D9F-44AB-4DD1-8E51-D0AFC8F9FE09 @default.
- Q91321154 P2093 Q91321154-9BD7A023-F125-4865-A36B-D429D1749DA3 @default.
- Q91321154 P304 Q91321154-26330605-6B6B-4123-9CFB-8ECEB8731249 @default.
- Q91321154 P31 Q91321154-C1AC9BB0-9A3F-4D91-BE1B-DB6CB3BE07E0 @default.
- Q91321154 P356 Q91321154-F81478E6-10F3-4A62-85C0-29508277BF36 @default.
- Q91321154 P433 Q91321154-EE645AD4-77EF-46BD-80EA-39870A7806A1 @default.
- Q91321154 P478 Q91321154-572A2E44-A2EF-4AFB-A5A6-B9FCF8DB5EE6 @default.
- Q91321154 P577 Q91321154-5D3FEDD5-7C6C-4B3A-A02A-D91AB8A058C3 @default.
- Q91321154 P698 Q91321154-5C9751E5-2021-4EB7-96E9-28DF49FB09BE @default.
- Q91321154 P921 Q91321154-9E72EEB3-C965-4A95-8B80-0027B8C60C55 @default.
- Q91321154 P356 IMT-2019-0178 @default.
- Q91321154 P698 31738117 @default.
- Q91321154 P1433 Q18713038 @default.
- Q91321154 P1476 "Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA" @default.
- Q91321154 P2093 "Flavia Ejzykowicz" @default.
- Q91321154 P2093 "Gilberto de Lima Lopes" @default.
- Q91321154 P2093 "Josephine L Feliciano" @default.
- Q91321154 P2093 "Min Huang" @default.
- Q91321154 P2093 "Ralph P Insinga" @default.
- Q91321154 P2093 "Thomas Burke" @default.
- Q91321154 P2093 "Ying Zhang" @default.
- Q91321154 P304 "1463-1478" @default.
- Q91321154 P31 Q13442814 @default.
- Q91321154 P356 "10.2217/IMT-2019-0178" @default.
- Q91321154 P433 "17" @default.
- Q91321154 P478 "11" @default.
- Q91321154 P577 "2019-11-18T00:00:00Z" @default.
- Q91321154 P698 "31738117" @default.
- Q91321154 P921 Q13896859 @default.